Manufacturing / Biological Products, Except Diagnostic Substances
Moderna, Inc.
MRNA
$63.90
-$0.06 (-0.09%)
19 B
Market Cap (Large Cap)
52%
IV Rank
79.7%
Implied Volatility
Jul 30
Next Earnings
Insider Trades
0 buys
9 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Jun 05, 2026 | Klinger Shannon Thyme | Exercise | 11,798 | $0 | |
| Jun 05, 2026 | Klinger Shannon Thyme | Tax_withholding | 5,705 | $294,321 | |
| Jun 05, 2026 | Klinger Shannon Thyme | Exercise | 11,798 | $0 | |
| Jun 05, 2026 | Mock James M | Exercise | 11,798 | $0 | |
| Jun 05, 2026 | Mock James M | Tax_withholding | 5,705 | $294,321 | |
| Jun 05, 2026 | Mock James M | Exercise | 11,798 | $0 | |
| Jun 05, 2026 | Klinger Shannon Thyme | Other | 11,798 | $0 | |
| Jun 05, 2026 | Klinger Shannon Thyme | Other | 5,705 | $294,321 | |
| Jun 05, 2026 | Klinger Shannon Thyme | Other | 11,798 | $0 | |
| Jun 05, 2026 | Mock James M | Other | 11,798 | $0 |
Politician Trades in MRNA
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| Aug 26, 2025 | Ro Khanna | D | Sale | $1K-$15K |
| Jul 25, 2025 | Ro Khanna | D | Purchase | $1K-$15K |
| May 19, 2025 | Ro Khanna | D | Sale | $1K-$15K |
| Apr 10, 2025 | Ro Khanna | D | Sale | $1K-$15K |
| Apr 08, 2025 | Robert P. Bresnahan | R | Sale | $1K-$15K |
| Feb 25, 2025 | Ro Khanna | D | Purchase | $1K-$15K |
| Feb 25, 2025 | Robert P. Bresnahan | R | Purchase | $1K-$15K |
| Feb 19, 2025 | Ro Khanna | D | Purchase | $1K-$15K |
| Jan 17, 2025 | Ro Khanna | D | Sale | $1K-$15K |
| Jan 15, 2025 | Julie Johnson | D | Sale | $1K-$15K |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | -$4.04 | -$3.40 | +15.8% | Beat |
| Dec 31, 2025 | Q4 2025 | -$2.70 | -$2.11 | +21.7% | Beat |
| Sep 30, 2025 | Q3 2025 | -$2.15 | -$0.51 | +76.3% | Beat |
| Jun 30, 2025 | Q2 2025 | -$3.03 | -$2.13 | +29.6% | Beat |
Track MRNA with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for MRNA and your entire portfolio.